These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 18757503)

  • 21. Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor.
    Lingerfelt MA; Zhao P; Sharir HP; Hurst DP; Reggio PH; Abood ME
    Biochemistry; 2017 Jan; 56(3):473-486. PubMed ID: 28005346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Blk-p190RhoGAP signaling module downstream of activated Gα13 functionally opposes CXCL12-stimulated RhoA activation and cell invasion.
    Bartolomé RA; Díaz-Martínez M; Coló GP; Arellano-Sánchez N; Torres-Ayuso P; Kleinovink JW; Mérida I; Teixidó J
    Cell Signal; 2014 Nov; 26(11):2551-61. PubMed ID: 25025568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity.
    Hurst K; Badgley C; Ellsworth T; Bell S; Friend L; Prince B; Welch J; Cowan Z; Williamson R; Lyon C; Anderson B; Poole B; Christensen M; McNeil M; Call J; Edwards JG
    Hippocampus; 2017 Sep; 27(9):985-998. PubMed ID: 28653801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Socius, a novel binding partner of Galpha12/13, promotes the Galpha12-induced RhoA activation.
    Tateiwa K; Katoh H; Negishi M
    Biochem Biophys Res Commun; 2005 Nov; 337(2):615-20. PubMed ID: 16202387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current.
    Lauckner JE; Jensen JB; Chen HY; Lu HC; Hille B; Mackie K
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2699-704. PubMed ID: 18263732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.
    Ford LA; Roelofs AJ; Anavi-Goffer S; Mowat L; Simpson DG; Irving AJ; Rogers MJ; Rajnicek AM; Ross RA
    Br J Pharmacol; 2010 Jun; 160(3):762-71. PubMed ID: 20590578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.
    Brown AJ; Daniels DA; Kassim M; Brown S; Haslam CP; Terrell VR; Brown J; Nichols PL; Staton PC; Wise A; Dowell SJ
    J Pharmacol Exp Ther; 2011 Apr; 337(1):236-46. PubMed ID: 21233197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling.
    Calvillo-Robledo A; Cervantes-Villagrana RD; Morales P; Marichal-Cancino BA
    Life Sci; 2022 Jul; 301():120596. PubMed ID: 35500681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G Protein betagamma subunits stimulate p114RhoGEF, a guanine nucleotide exchange factor for RhoA and Rac1: regulation of cell shape and reactive oxygen species production.
    Niu J; Profirovic J; Pan H; Vaiskunaite R; Voyno-Yasenetskaya T
    Circ Res; 2003 Oct; 93(9):848-56. PubMed ID: 14512443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counteracting effect of TRPC1-associated Ca2+ influx on TNF-α-induced COX-2-dependent prostaglandin E2 production in human colonic myofibroblasts.
    Hai L; Kawarabayashi Y; Imai Y; Honda A; Inoue R
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G356-67. PubMed ID: 21546578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of choline kinase by extracellular Ca2+ is Ca(2+)-sensing receptor, Galpha12 and Rho-dependent in breast cancer cells.
    Huang C; Hydo LM; Liu S; Miller RT
    Cell Signal; 2009 Dec; 21(12):1894-900. PubMed ID: 19716891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer.
    Andradas C; Blasco-Benito S; Castillo-Lluva S; Dillenburg-Pilla P; Diez-Alarcia R; Juanes-García A; García-Taboada E; Hernando-Llorente R; Soriano J; Hamann S; Wenners A; Alkatout I; Klapper W; Rocken C; Bauer M; Arnold N; Quintanilla M; Megías D; Vicente-Manzanares M; Urigüen L; Gutkind JS; Guzmán M; Pérez-Gómez E; Sánchez C
    Oncotarget; 2016 Jul; 7(30):47565-47575. PubMed ID: 27340777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.
    Hofmann NA; Yang J; Trauger SA; Nakayama H; Huang L; Strunk D; Moses MA; Klagsbrun M; Bischoff J; Graier WF
    Br J Pharmacol; 2015 Aug; 172(16):4107-18. PubMed ID: 25989290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The GPR55 agonist lysophosphatidylinositol acts as an intracellular messenger and bidirectionally modulates Ca2+ -activated large-conductance K+ channels in endothelial cells.
    Bondarenko AI; Malli R; Graier WF
    Pflugers Arch; 2011 Jan; 461(1):177-89. PubMed ID: 21072666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.
    Piñeiro R; Maffucci T; Falasca M
    Oncogene; 2011 Jan; 30(2):142-52. PubMed ID: 20838378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear factor of activated T cells mediates RhoA-induced fibronectin upregulation in glomerular podocytes.
    Zhu L; Qi XY; Aoudjit L; Mouawad F; Baldwin C; Nattel S; Takano T
    Am J Physiol Renal Physiol; 2013 Apr; 304(7):F849-62. PubMed ID: 23389455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible translocation of p115-RhoGEF by G(12/13)-coupled receptors.
    Meyer BH; Freuler F; Guerini D; Siehler S
    J Cell Biochem; 2008 Aug; 104(5):1660-70. PubMed ID: 18320579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors.
    Martínez-Aguilar LM; Ibarra-Sánchez A; Guerrero-Morán DJ; Macías-Silva M; Muñoz-Bello JO; Padilla A; Lizano M; González-Espinosa C
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction.
    Brighton PJ; Szekeres PG; Wise A; Willars GB
    Mol Pharmacol; 2004 Dec; 66(6):1544-56. PubMed ID: 15331768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. l-α-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK-dependent pathway.
    Robertson-Gray OJ; Walsh SK; Ryberg E; Jönsson-Rylander AC; Lipina C; Wainwright CL
    Pharmacol Res Perspect; 2019 Jun; 7(3):e00487. PubMed ID: 31149342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.